Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Analyst Ratings
B of A Securities Reiterates Sell Rating on CarMax, Inc.
B of A Securities maintains its sell rating on CarMax with a $45 target.
Analyst Ratings
B of A Securities Reiterates Buy Rating on The Progressive Corporation
B of A Securities maintains its buy rating on Progressive with a $313 target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on RLMD, Sets $12 Target
HC Wainwright reaffirms its positive outlook on RLMD with a $12 price target.
Analyst Ratings
B of A Securities Reaffirms Buy Rating on Immix Biopharma
The firm sets a $27 price target as shares trade around $9.13.
Analyst Ratings
Goldman Sachs Reiterates Buy Rating on Talen Energy
Goldman Sachs maintains its buy rating on Talen Energy with a $499 price target.
Analyst Ratings
Stifel Downgrades Intuit to Hold, Sets $275 Price Target
Stifel analyst Brad Reback lowers Intuit's rating to hold and sets a $275 price target.
Analyst Ratings
Raymond James Upgrades First Industrial Realty Trust, Inc. to 'Buy'
Raymond James analyst David Rodgers raises First Industrial Realty Trust, Inc. to 'buy' with an $83 target.
Analyst Ratings
Raymond James Upgrades EastGroup Properties to 'Buy'
Raymond James has reinstated EastGroup Properties with a 'buy' rating and a $241 price target.
Analyst Ratings
Raymond James Upgrades STAG to 'Buy'
Raymond James has upgraded its rating on STAG to 'buy' with a $44 price target.
Analyst Ratings
Needham Reiterates Buy Rating on Alkermes plc
Needham maintains its buy rating on Alkermes plc with a $54 price target.
Analyst Ratings
Needham Reiterates Buy Rating on Sezzle Inc.
Needham maintains its optimistic outlook on Sezzle, setting a price target of $166.
Analyst Ratings
Bernstein Reiterates Sell Rating on Ormat Technologies
Analyst Sunaina Ocalan sets a $115 target for Ormat Technologies.
Analyst Ratings
BTIG Reiterates Buy Rating on Evolus, Inc. (EOLS)
BTIG maintains its buy stance on Evolus with a $13 price target.
Analyst Ratings
HC Wainwright Reaffirms Buy Rating on Hemab Therapeutics
HC Wainwright maintains its buy rating on Hemab Therapeutics with a $40 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Silence Therapeutics
HC Wainwright maintains a buy rating on Silence Therapeutics, setting a $75 price target.
Analyst Ratings
Needham Reiterates Buy Rating for The Oncology Institute, Inc. (TOI)
Needham maintains its buy rating for The Oncology Institute, Inc. with a $7 price target.
Analyst Ratings
HC Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals
HC Wainwright maintains its buy rating on Phathom Pharmaceuticals with a $26 target.
Analyst Ratings
BTIG Upgrades TPG Mortgage Investment Trust to Buy
BTIG analyst Douglas Harter upgrades TPG Mortgage Investment Trust to Buy with a $9 price target.
Analyst Ratings
BTIG Reiterates Buy Rating on Angel Oak Mortgage REIT
BTIG continues to recommend Angel Oak Mortgage REIT with a $10 price target.
Analyst Ratings
BTIG Upgrades MFA Financial, Inc. to 'Buy' with New Price Target
BTIG analyst Douglas Harter raised MFA Financial's rating to 'buy' with a $10.5 price target.
Analyst Ratings
BTIG Reiterates Buy Rating for Redwood Trust, Inc.
BTIG maintains a buy rating on Redwood Trust, Inc. with a $6 price target.
Analyst Ratings
BTIG Reiterates Buy Rating for Velocity Financial
BTIG analyst Douglas Harter maintains a buy rating on Velocity Financial, Inc. with a $22 price target.
Analyst Ratings
Baird Reiterates Buy Rating for Schneider National, Inc.
Baird has reiterated its buy rating on Schneider National with a $39 price target.
Analyst Ratings
B of A Securities Downgrades Leidos Holdings to 'Hold'
Leidos Holdings receives a downgrade from B of A Securities with a new price target.